Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains

COPYRIGHTED MATERIAL, DO NOT REPRODUCE

By Jack B. Anon, MD; Berrylin Ferguson, MD; Monique Twynholm, MSc; Brian Wynne, MD; Elchonon Berkowitz, PhD; Michael D. Poole, MD, PhD


Please sign in with your existing account or create an account to log in and print full article content.


COPYRIGHT 2017 BY VENDOME GROUP. UNAUTHORIZED REPRODUCTION OR DISTRIBUTION STRICTLY PROHIBITED